Korean J Dermatol.  2017 Aug;55(7):427-434.

Pulsed Versus Continuous Cyclosporine Regimens for Maintenance Therapy in Psoriasis: A Comparative Study

Affiliations
  • 1Department of Dermatology, College of Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea. kkj51818@hallym.or.kr

Abstract

BACKGROUND
Psoriasis is a chronic recurrent disease requiring long-term treatment; therefore, special attention is warranted when prescribing cyclosporine A (CsA) for patients diagnosed with psoriasis. Various forms of maintenance therapy have been suggested to reduce the incidence of adverse events associated with CsA use.
OBJECTIVE
We aimed to compare the efficacy and safety of the three aforementioned CsA therapies for management of patients with psoriasis.
METHODS
Patients fulfilling our selection criteria were selected for the study. CsA therapy (2.5∼5 mg/kg/day) was administered for 12 weeks, and patients who showed remission following this treatment were administered maintenance therapy. Patients with successful induction of response were randomly assigned to three treatment groups. Group A was the continuous regimen group (2∼3 mg/kg/day). Group B was the pulsed regimen group (4 mg/kg/day for 4 days, 3 days of discontinuation). Group C was the weekend regimen group (5 mg/kg/day for 2 days, 5 days of discontinuation). Patients were followed up on an outpatient basis at 4-week intervals to monitor treatment effects.
RESULTS
In each group, the Psoriasis Area and Severity Index (PASI) and body surface area (BSA) values decreased in a similar fashion from visit 1 to visit 4 and at the time of the final visit 7. In each group, dermatology life quality index (DLQI) values showed statistically significant differences between pre- and post-treatment states; however, no inter-group differences were observed. Although adverse events such as elevated blood pressure and serum creatinine levels were slightly higher in the intermittent group, there was no significant inter-group difference.
CONCLUSION
The pulsed regimen did not show a major difference in treatment effects compared to the everyday use group. We propose that the patient's age, presence of underlying diseases, lifestyle patterns, and convenience of use should be considered while determining the type of regimen administered to a patient.

Keyword

Continuous regimens; Cyclosporine A; Weekend regimens; Pulsed regimens; Psoriasis

MeSH Terms

Blood Pressure
Body Surface Area
Creatinine
Cyclosporine*
Dermatology
Humans
Incidence
Life Style
Outpatients
Patient Selection
Psoriasis*
Quality of Life
Creatinine
Cyclosporine
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr